Details of the Drug

General Information of Drug (ID: DMA96KW)

Drug Name
ISIS 329956
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Antisense drug
Sequence
CCTGAGGCGGACTCCCAGCT
Cross-matching ID
TTD ID
D0Q4HW

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
CRP messenger RNA (CRP mRNA) TTWRN6M CRP_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 US patent application no. 7,425,545, Modulation of C-reactive protein expression.
2 Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies. J Pharmacol Toxicol Methods. 2014 Jan-Feb;69(1):49-60.
3 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2009).
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.